[1]
H. Kaghazian, “ANIMAL PRE-CLINICAL STUDY OF AN INACTIVATED SARSCoV-2 VACCINE CANDIDATE (OSVID-19 ®): IMMUNOGENICITY, PROTECTIVE, AND SAFETY ASPECTS”, J Popl Ther Clin Pharmacol, vol. 30, no. 17, pp. 333–353, Jul. 2023, doi: 10.53555/jptcp.v30i17.1555.